South-East Asia (WHO region) vs Tonga: New cases tested for RR-/MDR-TB
South-East Asia (WHO region)
91.0%
in 2024
Tonga
100.0%
in 2023
South-East Asia (WHO region) rank
1st
Tonga rank
1st
New cases tested for RR-/MDR-TB over time
- South-East Asia (WHO region)
- Tonga
How they compare
Tonga currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Tonga's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was South-East Asia (WHO region) ahead.
South-East Asia (WHO region) ranks 1st and Tonga ranks 1st of 11 groups.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.0% | 30.0% | 8.0% | Tonga |
| 2020s | 74.5% | 100.0% | 25.5% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South-East Asia (WHO region) or Tonga?
- Tonga, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between South-East Asia (WHO region) and Tonga?
- 9.0%, with Tonga ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Tonga?
- 14 years are reported by both, from 2010 to 2023.
- How do South-East Asia (WHO region) and Tonga rank globally for new cases tested for rr-/mdr-tb?
- South-East Asia (WHO region) ranks 1st and Tonga ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.